4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001415889-23-013899
Options or other derivatives
- Director acquired 61,676 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Ben Zvi Shmuel Director | 2023-09-29 | Grant or award · Stock Option (Right to Buy) | +61,676 | 61,676 | D | ||
Loading xslF345X05/form4-10032023_051016.xml…